Soria-Bretones, Isabel
Casás-Selves, Matias
Samanta, Minu
Groff, David https://orcid.org/0000-0001-6897-2656
Murray, Jayne
Fletcher, Jamie I. https://orcid.org/0000-0003-2949-9469
Farrel, Alvin https://orcid.org/0000-0003-1087-9840
Pastor, Steven https://orcid.org/0000-0002-4204-1383
Patel, Khushbu
Goodfellow, Elliot
Li, Li
Caron, Cathy
Shiwram, Ariya
Kim, Hyeyeon https://orcid.org/0000-0002-0489-7682
Henry, Danielle
Laterreur, Nancy
Bowlan, Julian
Krytska, Kateryna
Neuhauser, Steven B. https://orcid.org/0000-0002-2993-9324
Stearns, Timothy M.
Schubert, Jeffrey A.
Wu, Jinhua
Surrey, Lea F. https://orcid.org/0000-0002-6944-2232
Martinez, Daniel
Mak, Crystal
Brand, Jennifer
Wesley, Caitlin https://orcid.org/0009-0004-0340-6943
Somers, Klaartje https://orcid.org/0000-0002-7644-4121
Álvarez-Quilón, Alejandro
Vallée, Frédéric
Nejad, Parham
Schonhoft, Joseph D.
Li, Joanna
Veloso, Artur
Young, Jordan T. F.
Hyer, Marc L.
Morris, Stephen J.
Mossé, Yael P. https://orcid.org/0000-0002-3463-0399
Marshall, C. Gary
Haber, Michelle https://orcid.org/0000-0003-2036-8817
Zimmermann, Michal https://orcid.org/0000-0002-9955-1675
Maris, John M. https://orcid.org/0000-0002-8088-7929
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35 CA220500)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01 CA217959)
Department of Health | National Health and Medical Research Council (APP2017256)
Department of Health | National Health and Medical Research Council (APP2018642)
Department of Health | National Health and Medical Research Council (APP2017256)
Article History
Received: 6 July 2025
Accepted: 21 May 2026
First Online: 13 June 2026
Competing interests
: I.S.B., M.C.S., E.G., L.L., C.C., A.S., H.K., D.H., N.L., J.B., A.A.Q., F.V., P.N., J.D.S., J.L., A.V., J.T.F.Y., M.L.H., S.J.M., C.G.M. and M.Z. are current or former employees of Repare Therapeutics and receive(d) salary and/or equity compensation. This work was supported by sponsored research agreements from Repare Therapeutics to the Maris laboratory at the Children’s Hospital of Philadelphia and the Haber laboratory at Children’s Cancer Institute, Sydney. All other authors declare no competing interests.